对罕见疾病的系统视角:将人类表型本体学与阿尤尔韦达的Anukta框架集成在一起
Deepika Jangir1, Aditi Joshi2, Saketh Ram Thrigulla3
1Center of Excellence - Ayurtech, School of Artificial Intelligence and Data Science, IIT Jodhpur, Rajasthan, 342037, India.
Journal of Ayurveda and integrative medicine
|March 4, 2026
概括
艾尔维达是一种阿育韦德.
科学领域:
- 综合医学是一个整体的医学.
- 罕见疾病研究研究.
- 现象类型分析分析
背景情况:
- 罕见疾病往往被低诊断和管理不善.
- 阿尤尔韦达提供了一个基于系统的方法来理解未列出的条件 (Anukta Vyadhi).
- 人类表型本体学 (HPO) 标准化了罕见疾病表型.
研究的目的:
- 探索将阿育吠陀Anukta框架与HPO集成用于罕见疾病评估.
- 将阿育韦德分类与现代的表型词汇架起桥梁.
主要方法:
- 将140个纳纳特马贾维卡拉 (NV) 表型映射到HPO术语中.
- 在超过7200种罕见疾病中分析了NV表型的表现.
- 使用综合框架解释了特定罕见疾病的案例研究.
主要成果:
- 128个NV表型映射到199个HPO术语中,与Vata相关的特征是最普遍的.
- 超过7200种罕见疾病显示出Nanatmaja Vikara的代表性.
- 案例研究表明与瓦塔卡法,瓦塔皮塔和特里多沙不平衡存在关联.
结论:
- 整合Anukta框架与HPO提供了一种实际的方法来理解阿育吠陀中的罕见疾病.
- 这种整合支持罕见疾病的临床评估和整合性决策.
- 促进一个结构化的途径,在阿育吠陀的设置中管理罕见疾病.
相关概念视频
Classification of Illness
9.1K
The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
9.1K
Pharmacogenetics and Pharmacogenomics: Overview
88
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
88
Genomics
41.2K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
41.2K
Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
71
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
71
Pharmacogenomics: Identification of New Drug Targets
55
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
55


